Oral Medicine, Periodontology, Oral Diagnosis, and Oral Radiology Department, Faculty of Dentistry, Alexandria University, Champolion St, 21527, Alexandria Governorate, Egypt.
Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Alexandria University, Alexandria Governorate, Egypt.
BMC Oral Health. 2023 Aug 30;23(1):612. doi: 10.1186/s12903-023-03276-5.
Oral mucositis (OM) is recognized as one of the most frequent debilitating sequelae encountered by head and neck cancer (HNC) patients treated by radiotherapy. This results in severe mucosal tissue inflammation and oral ulcerations that interfere with patient's nutrition, quality of life (QoL) and survival. Omega-3 (ω-3) polyunsaturated fatty acids (PUFAs) have recently gained special interest in dealing with oral diseases owing to its anti-inflammatory, anti-oxidant and wound healing properties. Thus, this study aims to assess topical Omega-3 nanoemulgel efficacy in prevention of radiation-induced oral mucositis and regulation of oral microbial dysbiosis.
Thirty-four head and neck cancer patients planned to receive radiotherapy were randomly allocated into two groups: Group I: conventional preventive treatment and Group II: topical Omega-3 nanoemulgel. Patients were evaluated at baseline, three and six weeks after treatment using the World Health Organization (WHO) grading system for oral mucositis severity, Visual Analogue Scale (VAS) for perceived pain severity, and MD-Anderson Symptom Inventory for Head and Neck cancer (MDASI-HN) for QoL. Oral swabs were collected to assess oral microbiome changes.
VAS scores and WHO mucositis grades were significantly lower after six weeks of treatment with topical Omega-3 nanoemulgel when compared to the conventional treatment. The total MDASI score was significantly higher in the control group after three weeks of treatment, and the head and neck subscale differed significantly at both three and six weeks. A significant reduction in Firmicutes/Bacteroidetes ratio was observed after six weeks in the test group indicating less microbial dysbiosis.
Topical Omega-3 nanoemulgel demonstrated a beneficial effect in prevention of radiation-induced oral mucositis with a possibility of regulating oral microbial dysbiosis.
口腔黏膜炎(OM)是头颈部癌症(HNC)患者接受放疗后最常见的致残性后遗症之一。这会导致严重的黏膜组织炎症和口腔溃疡,从而干扰患者的营养、生活质量(QoL)和生存。由于具有抗炎、抗氧化和促进伤口愈合的特性,ω-3 多不饱和脂肪酸(PUFAs)最近在处理口腔疾病方面引起了特别关注。因此,本研究旨在评估局部ω-3 纳米乳凝胶在预防放射性口腔黏膜炎和调节口腔微生物失调方面的疗效。
34 名计划接受放疗的头颈部癌症患者被随机分为两组:I 组:常规预防治疗;II 组:局部ω-3 纳米乳凝胶。患者在基线、治疗后 3 周和 6 周时使用世界卫生组织(WHO)口腔黏膜炎严重程度分级系统、视觉模拟评分(VAS)评估疼痛严重程度以及 MD-Anderson 头颈部癌症症状量表(MDASI-HN)评估生活质量。采集口腔拭子以评估口腔微生物组的变化。
与常规治疗相比,局部ω-3 纳米乳凝胶治疗 6 周后,VAS 评分和 WHO 黏膜炎分级显著降低。治疗 3 周后,对照组的总 MDASI 评分显著升高,头颈部子量表在 3 周和 6 周时差异均有统计学意义。治疗 6 周后,实验组厚壁菌门/拟杆菌门比值显著降低,表明微生物失调减少。
局部ω-3 纳米乳凝胶在预防放射性口腔黏膜炎方面具有有益的作用,并且有可能调节口腔微生物失调。